Health Encyclopedia

Burkitt lymphoma

Definition

Burkitt lymphoma is a very fast growing form of non-Hodgkin's lymphoma.

Alternative Names

B-cell lymphoma; High-grade B-cell lymphoma; Small non-cleaved cell lymphoma

Causes, incidence, and risk factors

This type of tumor was first discovered in children in certain parts of Africa, but it also occurs in the United States.

The African type of Burkitt lymphoma is closely associated with the Epstein-Barr virus (EBV), the main cause of infectious mononucleosis. The North American form of Burkitt lymphoma is not linked to EBV.

The majority of Burkitt lymphoma cases are seen in males.

Symptoms

Burkitt lymphoma may first be noticed as a swelling of the lymph nodes (glands) in the neck, groin, below the jaw, or under the arm. These swollen lymph nodes are often painless, but can grow very rapidly.

In the more common types seen in the United States, the cancer usually starts in the belly area (abdomen). The disease can also start in the ovaries, testes, brain, and spinal fluid.

Symptoms include:

Nodes that grow together to form a lump
Non-tender nodes
Rapid growth of the lymph nodes
Unexplained swollen lymph nodes

Signs and tests

Bone marrow biopsy
Chest x-ray
CT scan of the chest, abdomen, and pelvis
Examination of the spinal fluid
Lymph node biopsy
PET or gallium scan

Treatment

Chemotherapy is used to treat this type of cancer. Commonly used medicines include prednisone, cyclophosphamide, vincristine, cytarabine, doxorubicin, methotrexate, and others.

Expectations (prognosis)

More than half of those with Burkitt lymphoma can be cured with intensive chemotherapy. The cure rate may be lower if the cancer spreads to the bone marrow or spinal fluid.

Complications

Complications of treatment (radiation therapy or chemotherapy)
Spread of the cancer

Calling your health care provider

Call your health care provider if you have symptoms of Burkitt lymphoma.

References

Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: p.1411.

Review Date:7/11/2008
Reviewed By:David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.